Holders over time
- LINE
- EQIX
| Quarter | LINE | EQIX |
|---|---|---|
| Q3 2020 | none listed holders, n.a. | 19 holders, $8.2bn |
| Q4 2020 | none listed holders, n.a. | 21 holders, $8.2bn |
| Q1 2021 | none listed holders, n.a. | 19 holders, $7.5bn |
| Q2 2021 | none listed holders, n.a. | 17 holders, $7.9bn |
| Q3 2021 | none listed holders, n.a. | 15 holders, $7.0bn |
| Q4 2021 | none listed holders, n.a. | 18 holders, $6.0bn |
| Q1 2022 | none listed holders, n.a. | 18 holders, $6.0bn |
| Q2 2022 | none listed holders, n.a. | 23 holders, $5.7bn |
| Q3 2022 | none listed holders, n.a. | 20 holders, $4.8bn |
| Q4 2022 | none listed holders, n.a. | 15 holders, $5.1bn |
| Q1 2023 | none listed holders, n.a. | 17 holders, $5.3bn |
| Q2 2023 | none listed holders, n.a. | 20 holders, $6.5bn |
| Q3 2023 | none listed holders, n.a. | 16 holders, $6.2bn |
| Q4 2023 | none listed holders, n.a. | 19 holders, $6.6bn |
| Q1 2024 | none listed holders, n.a. | 27 holders, $7.6bn |
| Q2 2024 | none listed holders, n.a. | 21 holders, $8.1bn |
| Q3 2024 | 16 holders, $1.5bn | 26 holders, $9.6bn |
| Q4 2024 | 12 holders, $1.1bn | 28 holders, $10.3bn |
| Q1 2025 | 9 holders, $1.3bn | 31 holders, $8.7bn |
| Q2 2025 | 11 holders, $1.0bn | 30 holders, $7.3bn |
| Q3 2025 | 7 holders, $646m | 28 holders, $7.0bn |
| Q4 2025 | 6 holders, $481m | 26 holders, $8.2bn |
| Q1 2026 | 4 holders, $341m | 31 holders, $11.5bn |
| Q2 2026 | 4 holders, $513m | 31 holders, $12.6bn |
Lineage Cell Theraputics In
- Holders
- 12
- Reported value
- $1.1bn
- Buyers
- 9
- Sellers
- 7
Breadth +2 among 94 comparable managers.
Equinix Inc
- Holders
- 28
- Reported value
- $10.3bn
- Buyers
- 19
- Sellers
- 10
Breadth +9 among 94 comparable managers.
Who holds both, Q4 2024
Both (7)
Artisan Partners LP, Capital Research Global Investors, Holocene Advisors LP, Janus Henderson Group Ltd, Schonfeld Strategic Advisors LLC, T. Rowe Price Associates Inc, Woodline Partners LP
Only LINE (5)
Baillie Gifford & Co, Capital World Investors, D1 Capital Partners LP, Freestone Grove Partners LP, Quantbot Technologies LP
Only EQIX (21)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Citadel Advisors LLC, D. E. Shaw & Co., ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Tudor Investment Corp, Two Sigma Advisers LP, Verition Fund Management LLC, Wellington Management Group LLP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.